Familiar Therapeutics
Latest round
- Seed
Last raised
- Oct 2026
Total raised
- $5M
Investors
- 4
About Familiar Therapeutics
, develops veterinary therapeutics and companion diagnostics by translating proven human medicines into novel treatments for dogs and cats with cancer, autoimmune, and metabolic diseases.
Who invested in Familiar Therapeutics
4 investors across 2 rounds
See all investors in Familiar Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Familiar Therapeutics
Who invested in Familiar Therapeutics?
Familiar Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Familiar Therapeutics raised?
Familiar Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Familiar Therapeutics last raise money?
Familiar Therapeutics's most recent round on record is a Seed, in Oct 2026.
What does Familiar Therapeutics do?
, develops veterinary therapeutics and companion diagnostics by translating proven human medicines into novel treatments for dogs and cats with cancer, autoimmune, and metabolic diseases.
Where is Familiar Therapeutics headquartered?
Familiar Therapeutics is headquartered in Redwood City, US.
Which VCs invest in companies like Familiar Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Familiar Therapeutics's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Familiar Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.